期刊文献+

非索非那定联合雷公藤多甙对慢性荨麻疹患者的疗效分析 被引量:15

Effect observation of fexofenadine combined with tripterygium glycosides in treating chronic urticaria
在线阅读 下载PDF
导出
摘要 目的研究雷公藤多甙(TG)对慢性荨麻疹(UC)患者的疗效。方法 2012年2月至2013年3月来该院就诊的UC患者91例,以数字法分成观察组(45例)和对照组(46例)。对照组予以非索非那定治疗,观察组另加服TG,对比两组治疗前后的UAS、VAS、LFS评分和疗效,血清IL-4、IFN-γ及IgE变化及不良反应。结果观察组治疗后的VAS、LFS及UAS评分显著低于治疗前及对照组治疗后的水平,疗效显著高于对照组,IL-4、IgE显著低于治疗前及对照组治疗后水平,IFN-γ显著高于治疗前及对照组治疗后水平,差异均有统计学意义(P<0.05)。两组不良反应差异无统计学意义(P>0.05)。结论 TG联合非索非那定治疗UC效果好。 Objective To study the effect of tripterygium glycosides(TG)in treating urticaria chronica(UC).Methods 91 cases of UC in our hospital from February 2012 to March 2013 were randomly divided into the observation group(45 cases)and the con-trol group(46 cases)according to the digital method.The control group was treated with fexofenadine,while on this basis the obser-vation group was added with TG.The UAS,VAS and LFS scores before and after treatment,curative effects,serum IL-4,IFN-γand IgE levels change and adverse reactions were compared between the two groups.Results The VAS,LFS and UAS scores after treatment in the observation group were significantly lower than those before treatment and the control group after treatment;the curative effect after 4-week treatment in the observation group was significantly higher than that in the control group;the IL-4 and IgE levels after treatment in the observation group were significantly lower than those before treatment and the control group after treatment;the IFN-γlevel was significantly higher than that before treatment and the control group after treatment,all the differ-ences above were statistically significant(P〈0.05).Adverse reactions had no statistically significant difference between two groups (P〉0.05).Conclusion TG combined with fexofenadine in the treatment of UC has better effect.
作者 陈慧君
出处 《重庆医学》 CAS CSCD 北大核心 2014年第25期3302-3304,共3页 Chongqing medicine
关键词 非索非那定 雷公藤多甙 荨麻疹 慢性病 治疗结果 UAS评分 fexofenadine tripterygium glycosides urticaria chronic disease treatment outcome UAS score
  • 相关文献

参考文献16

二级参考文献112

共引文献153

同被引文献139

  • 1侯静,曹灵,刘进,陈昕.特发性膜性肾病的免疫抑制疗法的系统综述与meta分析[J].中国生化药物杂志,2014,34(5):74-78. 被引量:6
  • 2刘勇.雷公藤多甙片联合地氯雷他定治疗慢性特发性荨麻疹的临床疗效观察[J].当代医药论丛,2014,12(1):299-300. 被引量:5
  • 3皮肖冰,王晓霞,麦玉妹,李洁华.雷公藤多苷联合咪唑斯汀治疗慢性特发性荨麻疹22例疗效观察[J].岭南皮肤性病科杂志,2006,13(2):130-132. 被引量:3
  • 4郑莜萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.143-150.
  • 5国家药典委员会中华人民共和国药典·临床用药须知·中药卷[M].北京:人民卫生出版社,2005.
  • 6Finlay AY,Khan GK. Dermatology Lift Quality Index (DLQI)-a simple practical measure for routine clinical use [ J ]. Clinical And Experimental Dermatology, 1994, 19 ( 3 ) : 210 -216.
  • 7Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guide- line : definition, classifieationand diagnosis of urticaria [ J ]. Allergy, 2009,64 ( 10 ) : 1417 - 1426.
  • 8Godse KV, Nadkarni N J, Nadkarni, N J, Ja- ni G, et al. Fexofenadine in Who doses in chronic what urticaria [J]. Journal of ipl Dermatol Online J ,2010,43 ( 8 ) :45 - 54.
  • 9Komarow HD, Metealfc DD. Office-based management of urticaria [J].American J kled,2008,221 : 379 - 384.
  • 10Waldman M, Austin HA. Treatment of idiopathic membra- nous nephropathy[J]. JAm Soc Neph, 2012,23(10) : 1 617.

引证文献15

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部